In 2007, programmed cell death-ligand 1 (PD-L1) was first identified as a new pancreatic cancer prognostic indicator due to the confirmation of up-regulation of PD-L1 expression in human pancreatic cancer cell [16]. The gene discussed is CD274; the disease is pancreatic neoplasm.